Current Topics in Medicinal Chemistry

Editor-in-Chief:

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

Back

Become EABM
Become Reviewer

Editorial [ Neuropeptide Y Receptors as Targets in Drug Discovery Guest Editor: Ambikaipakan Balasubramaniam ] promotion: free to download

Volume:7   Issue:17
Pp: 1644-1644
Ambikaipakan Balasubramaniam
DOI: 10.2174/156802607782340984

Relevance of Neuropeptide Y (NPY) in Psychiatry

Volume:7   Issue:17
Pp: 1645-1659
Katherine Eaton, Floyd R. Sallee and Renu Sah
DOI: 10.2174/156802607782341037

Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy

Volume:7   Issue:17
Pp: 1660-1674
Alfred Meurs, Ralph Clinckers, Guy Ebinger, Yvette Michotte and Ilse Smolders
DOI: 10.2174/156802607782340975

Relevance of the Neuropeptide Y System in the Biology of Cancer Progression

Volume:7   Issue:17
Pp: 1682-1691
M. Ruscica, E. Dozio, M. Motta and P. Magni
DOI: 10.2174/156802607782341019

NPY and Cardiac Diseases

Volume:7   Issue:17
Pp: 1692-1703
B. J. McDermott and D. Bell
DOI: 10.2174/156802607782340939

NPY and NPY Receptors in Vascular Remodeling

Volume:7   Issue:17
Pp: 1704-1709
Ken Abe, Jason U. Tilan and Zofia Zukowska
DOI: 10.2174/156802607782340948

NPY Family of Hormones: Clinical Relevance and Potential Use in Gastrointestinal Disease

Volume:7   Issue:17
Pp: 1710-1720
L. C. Vona-Davis and D. W. McFadden
DOI: 10.2174/156802607782340966

NPY Y2 and Y4 Receptors Selective Ligands: Promising Anti-Obesity Drugs?

Volume:7   Issue:17
Pp: 1734-1742
M. M. Kamiji and A. Inui
DOI: 10.2174/156802607782340957

NPY and Receptors in Immune and Inflammatory Diseases

Volume:7   Issue:17
Pp: 1743-1752
Julie Wheway, Herbert Herzog and Fabienne Mackay
DOI: 10.2174/156802607782341046

Molecule of the Month

Volume:7   Issue:17
Pp: 1753-1753
Kirk L. Stevens
DOI: 10.2174/156802607782341000